KR20250034534A - 대칭 디메틸아르기닌의 검출 - Google Patents

대칭 디메틸아르기닌의 검출 Download PDF

Info

Publication number
KR20250034534A
KR20250034534A KR1020257007101A KR20257007101A KR20250034534A KR 20250034534 A KR20250034534 A KR 20250034534A KR 1020257007101 A KR1020257007101 A KR 1020257007101A KR 20257007101 A KR20257007101 A KR 20257007101A KR 20250034534 A KR20250034534 A KR 20250034534A
Authority
KR
South Korea
Prior art keywords
sdma
antibody
affinity
protein
mma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020257007101A
Other languages
English (en)
Korean (ko)
Inventor
홍지 시
스리니바사 라오 라미세티
무르티 브이에스엔 예라밀리
Original Assignee
아이덱스 래보러토리즈, 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 아이덱스 래보러토리즈, 인코포레이티드 filed Critical 아이덱스 래보러토리즈, 인코포레이티드
Priority claimed from KR1020207013888A external-priority patent/KR102902843B1/ko
Publication of KR20250034534A publication Critical patent/KR20250034534A/ko
Pending legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54353Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366Apparatus specially adapted for solid-phase testing
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/563Immunoassay; Biospecific binding assay; Materials therefor involving antibody fragments
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6806Determination of free amino acids
    • G01N33/6812Assays for specific amino acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/583Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with non-fluorescent dye label
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/60Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances involving radioactive labelled substances

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biophysics (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
KR1020257007101A 2017-10-19 2018-10-19 대칭 디메틸아르기닌의 검출 Pending KR20250034534A (ko)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US201762574592P 2017-10-19 2017-10-19
US62/574,592 2017-10-19
US201762599117P 2017-12-15 2017-12-15
US62/599,117 2017-12-15
PCT/US2018/056687 WO2019079707A1 (en) 2017-10-19 2018-10-19 SYMMETRIC DIMETHYLARGININE DETECTION
KR1020207013888A KR102902843B1 (ko) 2017-10-19 2018-10-19 대칭 디메틸아르기닌의 검출

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR1020207013888A Division KR102902843B1 (ko) 2017-10-19 2018-10-19 대칭 디메틸아르기닌의 검출

Publications (1)

Publication Number Publication Date
KR20250034534A true KR20250034534A (ko) 2025-03-11

Family

ID=66170983

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020257007101A Pending KR20250034534A (ko) 2017-10-19 2018-10-19 대칭 디메틸아르기닌의 검출

Country Status (11)

Country Link
US (2) US11422136B2 (enExample)
EP (1) EP3697499A4 (enExample)
JP (1) JP7398366B2 (enExample)
KR (1) KR20250034534A (enExample)
CN (1) CN111246918B (enExample)
AU (1) AU2018351349B2 (enExample)
CA (1) CA3079011A1 (enExample)
MX (1) MX2020003523A (enExample)
TW (1) TWI831753B (enExample)
WO (1) WO2019079707A1 (enExample)
ZA (1) ZA202002415B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010017089A1 (en) * 2008-08-07 2010-02-11 Idexx Laboratories, Inc. Methods for detecting symmetrical demethylarginine
KR102492243B1 (ko) * 2015-02-20 2023-01-25 아이덱스 래보러토리즈, 인코포레이티드 배경 신호에 대한 보상에 의한 균질 면역검정
CA3079011A1 (en) * 2017-10-19 2019-04-25 Idexx Laboratories, Inc. Detection of symmetrical dimethylarginine
US10745492B1 (en) 2019-04-03 2020-08-18 Ark Diagnostics, Inc. Antibodies to symmetrically dimethylated arginine analytes and use thereof
EP4025301A4 (en) 2019-09-05 2023-07-19 The Regents of the University of California NON-INVASIVE METHOD FOR QUANTIFYING KIDNEY FUNCTION AND FUNCTIONAL DECLINE
CN113125697B (zh) * 2019-12-31 2024-03-26 科美博阳诊断技术(上海)有限公司 一种睾酮均相化学发光检测试剂盒及其应用
CN115843342A (zh) 2020-04-17 2023-03-24 艾德克斯实验室公司 荧光淬灭免疫测定
WO2022133159A1 (en) 2020-12-17 2022-06-23 Nephrosant, Inc. Kits for stabilization of urine samples
WO2025070448A1 (ja) * 2023-09-26 2025-04-03 富士フイルム株式会社 対称性ジメチルアルギニンを測定するためのキットおよび対称性ジメチルアルギニンの測定方法
WO2025205769A1 (ja) * 2024-03-26 2025-10-02 富士フイルム株式会社 α-アミラーゼと対称性ジメチルアルギニンとのコンジュゲート、およびその応用

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3875011A (en) 1972-11-06 1975-04-01 Syva Co Enzyme immunoassays with glucose-6-phosphate dehydrogenase
DE3134787A1 (de) 1981-09-02 1983-03-10 Boehringer Mannheim Gmbh, 6800 Mannheim Creatinin-antikoerper
IT1199088B (it) * 1984-03-09 1988-12-30 Miles Italiana Saggio di legame specifico mediante impiego di anti-g6pdh come marcante
US4818703A (en) 1985-10-23 1989-04-04 Pizzolante John M Stabilized alkaline picrate reagent for jaffe creatinine determination
EP0356160A3 (en) 1988-08-24 1991-09-11 The Board Of Trustees Of The Leland Stanford Junior University Capillary device
US5238652A (en) * 1990-06-20 1993-08-24 Drug Screening Systems, Inc. Analytical test devices for competition assay for drugs of non-protein antigens using immunochromatographic techniques
US5726010A (en) 1991-07-31 1998-03-10 Idexx Laboratories, Inc. Reversible flow chromatographic binding assay
US6455288B1 (en) 1993-04-08 2002-09-24 Dade Behring Marburg Gmbh Homogeneous immunoassays using mutant glucose-6-phosphate dehydrogenases
US5710009A (en) * 1994-02-17 1998-01-20 Serex, Inc. Receptor:release ligand (reland) complexes and release assays using said reland and methods and kits based thereon
US5804452A (en) 1995-04-27 1998-09-08 Quidel Corporation One step urine creatinine assays
AU7269098A (en) 1997-05-01 1998-11-24 Cooke Pharma, Inc. Cardiovascular disease risk assessment
US6736957B1 (en) 1997-10-16 2004-05-18 Abbott Laboratories Biosensor electrode mediators for regeneration of cofactors and process for using
US6358699B1 (en) 1999-02-05 2002-03-19 Cooke Pharma Assay for asymmetrical NG, NG dimethyl-l-arginine
AU2452301A (en) 1999-12-22 2001-07-03 Research Foundation Of The State University Of New York, The Protein methylarginine-specific antibodies
JP2004502948A (ja) * 2000-07-06 2004-01-29 ファル ダイアグノスティクス アルギニン化合物の検出のための方法及びキット
AU2001293699A1 (en) 2000-07-12 2002-01-21 Werner Naser Direct assessment of analyte to reference molecule ratios
DE10040904A1 (de) 2000-08-18 2002-02-28 Boeger Rainer H Verfahren und Mittel zum Nachweis einer Wahrscheinlichkeit zukünftigen Fortschreitens von Gefässerkrankungen
US7241856B2 (en) 2003-06-02 2007-07-10 Pentron Clinical Technologies Llc Dental resins, dental composite materials, and method of manufacture thereof
FR2824825B1 (fr) 2001-05-15 2005-05-06 Servier Lab Nouveaux derives d'alpha-amino-acides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
JP4214271B2 (ja) 2002-10-15 2009-01-28 アークレイ株式会社 クレアチニン測定用試験片
US7501053B2 (en) 2002-10-23 2009-03-10 Abbott Laboratories Biosensor having improved hematocrit and oxygen biases
AU2003290784A1 (en) * 2002-11-15 2004-06-15 The Board Of Trustees Of The Leland Stanford Junior University Methods for detecting asymmetric dimethylarginine in a biological sample
JP2004279412A (ja) * 2003-02-24 2004-10-07 Sanwa Kagaku Kenkyusho Co Ltd 低分子化合物の免疫学的測定・検出方法
US20050148029A1 (en) 2003-09-29 2005-07-07 Biosite, Inc. Methods and compositions for determining treatment regimens in systemic inflammatory response syndromes
JP4980884B2 (ja) * 2004-03-30 2012-07-18 ジーイー・ヘルスケア・バイオサイエンス・コーポレイション 側方流動方式、材料、及び方法
DE602004020360D1 (de) 2004-11-04 2009-05-14 Germediq Forsch & Entw Ges Mbh Methode zur Bestimmung von Arginin, methylierten Argininen und deren Derivate
CN1786713A (zh) * 2004-12-09 2006-06-14 陈金华 酶标仪在胶乳增强免疫透射比浊法中的应用
WO2006078813A2 (en) * 2005-01-21 2006-07-27 Biosite Incorporated Arginine analogs, and methods for their synthesis and use
JP5628476B2 (ja) * 2005-04-28 2014-11-19 ベンタナ・メデイカル・システムズ・インコーポレーテツド 抗体コンジュゲート
DE102005060057A1 (de) 2005-12-15 2007-06-28 Kellner, Karl-Heinz, Dr. Sandwich-Immunoassay für kleine Haptenmoleküle
JP2007176872A (ja) 2005-12-28 2007-07-12 Sentan Seimei Kagaku Kenkyusho:Kk アシンメトリックジメチルアルギニンを認識する抗体及びその製造方法並びに翻訳後修飾アミノ酸含有タンパク質の検出方法
FR2919063B1 (fr) 2007-07-19 2009-10-02 Biomerieux Sa Procede de dosage du leucocyte elastase inhibitor pour le diagnostic in vitro du cancer colorectal.
CA2708033C (en) 2007-12-05 2019-07-02 King's College London Methods and compositions
WO2010017089A1 (en) 2008-08-07 2010-02-11 Idexx Laboratories, Inc. Methods for detecting symmetrical demethylarginine
JP2012529015A (ja) 2009-06-02 2012-11-15 バイオクラテス ライフ サイエンシーズ アーゲー 腎臓疾患評価用新規バイオマーカー
CN101587118B (zh) 2009-07-03 2012-09-12 长春迪瑞医疗科技股份有限公司 肌酐尿液分析试纸及制备方法
CN101598727B (zh) 2009-07-09 2012-10-10 上海科华生物工程股份有限公司 定量测定人体血液尿素含量的干化学试纸
CN101865911A (zh) 2010-03-16 2010-10-20 苏州市玮琪生物科技有限公司 一种尿肌酐定量检测卡
JP5974892B2 (ja) * 2010-08-31 2016-08-23 コニカミノルタ株式会社 生体物質検出方法
DE102011055265A1 (de) 2010-11-17 2012-05-24 Karl-Heinz Kellner Automatenfähiger Immunoassay für biogene Amine
JP2012112785A (ja) 2010-11-24 2012-06-14 Tohoku Univ 透析膜の評価方法
US8394647B2 (en) * 2011-02-17 2013-03-12 Siemens Healthcare Diagnostics Inc. Reducing non-covalently bound polysaccharide on supports
CN102628868B (zh) * 2011-12-30 2014-09-17 北京九强生物技术股份有限公司 检测非对称二甲基精氨酸含量的胶乳增强免疫比浊法试剂盒
CN104204794B (zh) * 2012-01-10 2017-07-11 艾德克斯实验室公司 免疫分析测试载玻片
US20140038203A1 (en) 2012-07-09 2014-02-06 Musc Foundation For Research Development Methods for detecting or predicting kidney disease
US9304126B2 (en) 2012-08-21 2016-04-05 Janssen Pharmaceutica Nv Haptens of quetiapine
DK3041576T3 (da) * 2013-09-05 2019-09-09 Idexx Lab Inc Fremgangsmåder til at detektere nyresygdom
KR102492243B1 (ko) 2015-02-20 2023-01-25 아이덱스 래보러토리즈, 인코포레이티드 배경 신호에 대한 보상에 의한 균질 면역검정
CA3079011A1 (en) 2017-10-19 2019-04-25 Idexx Laboratories, Inc. Detection of symmetrical dimethylarginine
CN108469419A (zh) * 2018-03-09 2018-08-31 山东泰邦生物制品有限公司 采用酶标仪免疫透射比浊法高通量检测IgG含量的方法

Also Published As

Publication number Publication date
BR112020007150A2 (pt) 2020-09-24
US20190120856A1 (en) 2019-04-25
TWI831753B (zh) 2024-02-11
AU2018351349B2 (en) 2025-08-14
ZA202002415B (en) 2023-09-27
US11422136B2 (en) 2022-08-23
EP3697499A1 (en) 2020-08-26
JP2021500551A (ja) 2021-01-07
KR20200073259A (ko) 2020-06-23
CN111246918B (zh) 2024-06-14
MX2020003523A (es) 2020-07-22
EP3697499A4 (en) 2021-07-21
US20230102277A1 (en) 2023-03-30
TW201923349A (zh) 2019-06-16
CA3079011A1 (en) 2019-04-25
CN111246918A (zh) 2020-06-05
JP7398366B2 (ja) 2023-12-14
AU2018351349A1 (en) 2020-04-23
WO2019079707A1 (en) 2019-04-25

Similar Documents

Publication Publication Date Title
US20230102277A1 (en) Detection of symmetrical dimethylarginine
US20220221446A1 (en) Methods for Detecting Symmetrical Dimethylarginine
JP6226976B2 (ja) 多重特異性結合物を検出するための方法
US10458981B2 (en) Three-step acid dissociation enzyme linked immunosorbent (TADELIS) assay
JP2021181994A (ja) 腎疾患の検出方法
JP2022528465A (ja) 対称性ジメチル化アルギニン分析物に対する抗体及びその用途
KR102902843B1 (ko) 대칭 디메틸아르기닌의 검출
US9127039B2 (en) Sulfur-containing amino acid derivative
WO2021060496A1 (ja) 光切断リンカーの光切断効率向上方法、光切断リンカー結合磁性粒子、並びに、対象物質を測定する測定方法及びこれに用いるためのキット
BR112020007150B1 (pt) Métodos e kit para determinação de dimetilarginina simétrica (sdma) em uma amostra, dispositivo, reagente de captura, fase sólida e composição de um derivado de arginina
TW202204329A (zh) 螢光淬滅免疫分析
JP2003083966A (ja) 抗原/抗体水溶液

Legal Events

Date Code Title Description
A107 Divisional application of patent
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20250304

Application number text: 1020207013888

Filing date: 20200514

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20250401

Comment text: Request for Examination of Application